Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study
经动脉化疗栓塞术(TACE)联合免疫疗法和抗血管生成药物治疗中晚期肝细胞癌(CHANCE2202):一项靶向试验模拟研究
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103766
Chen, Jian-Jian; Jin, Zhi-Cheng; Zhou, Jia-Wei; Ding, Rong; Tie, Jun; Xin, Yu-Jing; Zhang, Lan; Huang, Ming; Zhu, Xiao-Li; Zhou, Guan-Hui; Ji, Fanpu; Zhu, Kang-Shun; Shi, Hai-Bin; Wu, Ye-Ming; Zhang, Wei-Hua; Yang, Wei-Zhu; Ding, Wen-Bin; Chen, Jin-Zhang; Ji, Jian-Song; Xu, Ai-Bing; Zhao, Wei; Wang, Qi; Dai, Zhen-Yu; Zheng, Chuan-Sheng; Zhao, Jin-Wei; Liu, Rui-Bao; Wu, Jian-Bing; Cao, Guang-Shao; Xing, Wen-Ge; Duan, Xu-Hua; Shao, Hai-Bo; Zhong, Bin-Yan; Zhao, Yang; Zhu, Hai-Dong; Ren, Zheng-Gang; Teng, Gao-Jun